Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)

Open Date (Earliest Submission Date): April 07, 2025
Expiration Date: January 08, 2028

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Award Budget

The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year.

Award Project Period

The total project period may not exceed 2 years.

Additional details about the R21 can be found here.